GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by New York Life Investment Management LLC

New York Life Investment Management LLC lowered its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,896 shares of the company’s stock after selling 323 shares during the period. New York Life Investment Management LLC’s holdings in GE HealthCare Technologies were worth $4,322,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also made changes to their positions in the company. Chicago Capital LLC boosted its position in shares of GE HealthCare Technologies by 2.8% during the 3rd quarter. Chicago Capital LLC now owns 6,081 shares of the company’s stock worth $414,000 after acquiring an additional 163 shares in the last quarter. Chilton Capital Management LLC lifted its position in shares of GE HealthCare Technologies by 15.4% during the 4th quarter. Chilton Capital Management LLC now owns 1,227 shares of the company’s stock worth $95,000 after buying an additional 164 shares during the last quarter. Procyon Advisors LLC boosted its holdings in shares of GE HealthCare Technologies by 5.2% in the 4th quarter. Procyon Advisors LLC now owns 3,555 shares of the company’s stock valued at $275,000 after buying an additional 175 shares in the last quarter. Meeder Advisory Services Inc. boosted its stake in GE HealthCare Technologies by 5.4% in the fourth quarter. Meeder Advisory Services Inc. now owns 3,634 shares of the company’s stock valued at $281,000 after acquiring an additional 185 shares in the last quarter. Finally, Forum Financial Management LP increased its position in shares of GE HealthCare Technologies by 3.9% during the third quarter. Forum Financial Management LP now owns 4,989 shares of the company’s stock worth $339,000 after purchasing an additional 186 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GEHC stock opened at $79.47 on Friday. The company has a market cap of $36.27 billion, a price-to-earnings ratio of 23.24, a PEG ratio of 2.86 and a beta of 1.26. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.11. The firm has a 50 day moving average of $88.25 and a 200-day moving average of $78.89. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.90. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The business had revenue of $4.65 billion during the quarter, compared to analysts’ expectations of $4.80 billion. During the same quarter last year, the business posted $0.85 earnings per share. The business’s revenue for the quarter was down 1.2% on a year-over-year basis. As a group, equities analysts expect that GE HealthCare Technologies Inc. will post 4.27 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio is presently 3.51%.

Analysts Set New Price Targets

GEHC has been the subject of several research analyst reports. Bank of America decreased their price objective on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating for the company in a report on Wednesday. Evercore ISI lifted their price objective on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research note on Thursday, April 4th. Mizuho decreased their target price on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research note on Wednesday. Citigroup boosted their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Finally, HSBC began coverage on GE HealthCare Technologies in a research report on Thursday, February 15th. They set a “buy” rating and a $100.00 price objective for the company. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $95.00.

Insider Buying and Selling

In related news, insider Frank R. Jimenez acquired 1,315 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, May 1st. The shares were acquired at an average cost of $76.52 per share, for a total transaction of $100,623.80. Following the completion of the transaction, the insider now directly owns 75,796 shares of the company’s stock, valued at $5,799,909.92. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.